All In Biotech

Free tool

FAERS Monitor: Zinc Chloride In Plastic Container

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 018959 or its brand name (Zinc Chloride In Plastic Container, Zinc Chloride). Reports on generic versions are filed under their own applications.

Reports

25,335

Serious

14,263

56% of reports

Hospitalization

6,323

Death reported

1,542

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue2,685
  • pain2,007
  • nausea1,991
  • diarrhoea1,922
  • headache1,903
  • off label use1,871
  • drug ineffective1,640
  • dyspnoea1,509
  • dizziness1,370
  • arthralgia1,363
  • fall1,278
  • asthenia1,265
  • constipation1,155
  • rash1,109
  • cough1,023

Reports by year received

View as table
YearReports
200486
2005100
2006115
2007117
2008144
2009199
2010282
2011284
2012188
2013443
2014591
2015937
20161,063
2017923
20181,056
20191,078
20201,835
20213,033
20223,318
20232,629
20242,494
20252,550
20261,870

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,028,824 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
constipationSignal1,1554.44.23,063
fallSignal1,2783.23.01,950
coughSignal1,0233.02.91,408
fatigueSignal2,6852.92.83,382
astheniaSignal1,2652.82.71,483
arthralgiaSignal1,3632.72.61,514
painSignal2,0072.72.62,236
headacheSignal1,9032.52.41,799
diarrhoeaSignal1,9222.52.41,738
dizzinessSignal1,3702.32.21,009
dyspnoeaSignal1,5092.22.11,031
rashSignal1,1092.12.0663
nauseaSignal1,9912.12.01,174
off label use1,8711.81.7659
drug ineffective1,6401.01.02

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.